Organization
Hospital General Universitario Gregorio Marañón, Madrid, Spain
2 abstracts
Abstract
Interim results of the randomized phase 2 cohort of study FW-2020-01 assessing the efficacy, safety and pharmacodynamics of CM24 in combination with nivolumab and chemotherapy in advanced/metastatic pancreatic cancer.Org: Gastrointestinal and Endocrine Tumor Unit Vall d'Hebron University Hospital and Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain, Yale University School of Medicine, New Haven, CT, Sheba Medical Center, Ramat Gan, and Tel Aviv University, Tel Aviv, Israel, Rambam Medical Center, Haifa, Israel, HonorHealth Research Institute, Scottsdale, AZ,
Abstract
Impact of histology on the efficacy and safety of pembrolizumab (pembro) monotherapy for advanced urothelial carcinoma (UC) in the phase 3 KEYNOTE-045 and KEYNOTE-361 trials.Org: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, Cliniques Universitaires Saint-Luc (UCLouvain), Brussels, Belgium, Aichi Medical University, Nagakute, Japan, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Tokyo Medical and Dental University Hospital, Tokyo, Japan,